Trabeculectomy outcomes.
Lachkar
Yves
Y
Cohn
Howard
H
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003228:Conjunctiva / Q000187:drug effects* / Q000473:pathology; D017889:Exfoliation Syndrome / Q000601:surgery; D005355:Fibrosis / Q000517:prevention & control; D015812:Glaucoma, Angle-Closure / Q000601:surgery*; D005902:Glaucoma, Open-Angle / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D012307:Risk Factors; D014130:Trabeculectomy; D053781:Transforming Growth Factor beta2 / Q000276:immunology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053781:Transforming Growth Factor beta2; C475848:Lerdelimumab